It is our pleasure to announce the 16th edition of the International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy. The tentative date and location is 26 - 28 May 2015, in the Washington DC area.
Understanding the clinical pharmacology of antiviral therapy is pivotal to designing optimal treatment and prevention strategies for HIV & Hepatitis infection. Drug exposure is significantly influenced by drug interactions, medication taking behavior, and patients’ physiologic and genetic characteristics. These factors are central to determining therapeutic efficacy, failure or toxicity. Despite great progress, many pharmacologic challenges still exist.
The 16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy will provide a platform for state-of-the-art discussions of current topics fundamental to the optimal use of antiviral therapy including drug-drug interactions, pharmacokinetics of investigational agents and existing drugs, pharmacodynamics, drug dosing in special populations, post-marketing surveillance, and regulatory considerations.
We invite you to attend the 16th International Workshop on Clinical Pharmacology of HIV & Hepatitis Therapy and encourage you to submit abstracts on your research in this field. Young investigators with an accepted abstract receive a free registration!
We look forward to welcoming you to the workshop in 2015!
The Program Committee